【摘要】 目的:观察神经妥乐平肌内注射治疗神经源性疼痛的疗效。方法:20例神经源性疼痛患者,以神经妥乐平3.6 U/次,肌内注射,2次/d,连续14 d为1疗程,记录治疗前后患者VAS评分以及不良反应。结果:所有患者治疗14 d后VAS评分较治疗前明显降低;伴随症状改善明显,未出现明显不良反应。结论:神经妥乐平注射治疗神经源性疼痛有效、安全、简便。更多还原

【Abstract】 Objectives: To assess the management of neuropathic pain using neurotropin by intramuscular injection.Methods: 40 patients with neuropathic pain were randomly divided into two groups.The control group only adminatrated with Celebrex at dosage of 0.2 g twice daily,and the trial group receiving nerotropnin at dosage of 3.6 U by intramuscular injection twice daily,the course of treatment both were 14 days.Results: The value of VAS decreased significantly after administration compared with pretreatment in all of the patients,and their simultaneous phenomenon improved markedly without apparent adverse reactions.Conclusion: The results suggest that it is effective,safe and convenient on the management of neuropathic pain using neurotropin by intramuscular injection.更多还原